Filing Details

Accession Number:
0001209191-15-018279
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-25 10:20:50
Reporting Period:
2015-02-23
Filing Date:
2015-02-25
Accepted Time:
2015-02-25 10:20:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1054905 Innospec Inc. IOSP Chemicals & Allied Products (2800) 981081725
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368260 Ian Cleminson 8310 South Valley Highway
Suite 350
Englewood CO CO8112
Vp & Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Commons Stock Acquisiton 2015-02-23 848 $0.00 25,724 No 4 M Direct
Common Stock Acquisiton 2015-02-24 1,909 $29.56 27,633 No 4 M Direct
Common Stock Disposition 2015-02-24 1,578 $43.92 26,055 No 4 F Direct
Common Stock Acquisiton 2015-02-24 5,092 $0.00 31,147 No 4 M Direct
Common Stock Disposition 2015-02-24 5,092 $43.90 26,055 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Acquisiton 2015-02-23 1,677 $43.95 1,677 $43.95
Common Stock Stock Options Acquisiton 2015-02-23 4,610 $0.00 4,610 $0.00
Common Stock Stock Options Disposition 2015-02-23 848 $0.00 848 $0.00
Common Stock Stock Options Disposition 2015-02-24 1,909 $29.56 1,909 $29.56
Common Stock Stock Options Disposition 2015-02-24 5,249 $0.00 5,249 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,232 2018-02-23 2025-02-23 No 4 A Direct
27,842 2018-02-23 2025-02-23 No 4 A Direct
26,994 2015-02-23 2022-02-23 No 4 M Direct
25,085 2015-02-23 2022-02-23 No 4 M Direct
19,836 2015-02-23 2022-02-23 No 4 M Direct
Footnotes
  1. Shares of common stock withheld to pay acquisition price and tax and social securities liabilities
  2. 97% of the PRSOP granted